Alergia en Lactantes R.H. ZARAGOZA URDAZ, MD, PhD ALLERGY
Transcription
Alergia en Lactantes R.H. ZARAGOZA URDAZ, MD, PhD ALLERGY
Allergies and Breast Feeding R.H. ZARAGOZA URDAZ, MD, PhD ALLERGY/IMMUNOLOGY DIAGNOSTIC IMMUNOLOGY FAAAAI, FACAAI & FAAEM AMPRO 9/04/04 MAYAGUEZ RESORT & CASINO R.H. ZARAGOZA URDAZ, M.D. College: Washington University, St. Louis, Mo. BS./ BA., 1983 Medical School: University of Puerto Rico School of Medicine, San Juan, PR. MD., 1987 Residency: University of Miami, Jackson Memorial Hospital, IM/Pediatrics, July, 1987 to June, 1990 Fellowship: National Jewish Center for Immunology and Respiratory Medicine; Allergy and Immunology, July 1990 to June 1994 National Jewish Center for Immunology and Respiratory Medicine; Diagnostic Laboratory Immunology, September 1992 to June 1994 OBJECTIVES To review current views of the pathogenesis of allergic reactions. To review the materno-placento-fetal immune interactions. To review the role of Lactation in prevention and/or induction of atopic disorders. To review the role of allergen avoidance (both food and aeroallergens) in the primary and secondary prevention of atopic disorders. INTRODUCTION Atopy is defined as the genetic propensity to develop IgE following allergen exposure (sensitization) and manifests clinically as allergic asthma, allergic rhinitis, atopic dermatitis and IgE-mediated food allergy. The exponential rise in the prevalence of asthma and related allergic disorders in the last 30 years has put an enormous burden on health care resources and adversely affected the quality of life of millions of children and adults. This emphasizes the need for devising effective methods for prevention in children at high risk of Atopy. INTRODUCTION Developed nations are experiencing a marked increase in prevalence of the familial allergic diseases including asthma, allergic rhinitis, atopic dermatitis, and allergic gastroenteropathy, which are often called atopic diseases. No satisfactory explanation for this epidemic is known, but it has been proposed that some facets of modern life tend to bias immune responses away from the Th1 cellular immune responses that protect against many infections and toward Th2 responses that favor atopy. There are 3 hypotheses to explain why this epidemic is occurring now. PATHOGENESIS Allergic states pathogenesis are complex polygenic disorders dependent on multilayered gene-environment-time interactions. The genes relevant to the development of allergic disorders might vary depending on the environmental exposures present in a given population; likewise, the relevant environmental exposure will be dependent on the genetic context. PATHOGENESIS The immunologic milieu at any given time will be determined by the individual’s cumulative environmental exposures and his or her genetically influenced responses to these exposures. Pathogenesis of Allergic Reactions ..\My DVDs\Asthma Pathophysiology\Asthma Pathophysiology2\Asthma Pathophysiology2.dvd ALLERGIC MARCH The allergic march starts in the womb. The intrauterine fetal sensitization is determined by the genetic background and is modified by the maternal environmental exposures including the diet. There is recent evidence that suggest that neonatal hygiene or early exposure to certain proteins, allergens or infections may modified the balance of important Tcells regulators which may skew the disease expression away from an allergic profile. Later on in life, these infections and exposure to pollutants may trigger a progressive evolution of allergic symptoms in genetically predisposed individuals. ALLERGEN AVOIDANCE & PREVENTION OF ATOPY Primary prevention Development of atopic disease depends on an interaction between genetic and environmental factors. Hence manipulation of environmental risk factors may lead to a reversal of this trend. – Allergen exposure and development of Atopy Dose-dependent relationship between allergen exposure and sensitization and between sensitization and the development of allergic disease is well established. – Allergens Food Allergens-- early life– cow’s milk, egg and peanut. Aeroallergens– humid climates– house dust mite-arid climates-fungus spores inner cities-cockroach 2-10 μg/g dust – Time of contact with allergen Evidence in dogs, early sensitization results in a higher level of IgE production, influences the direction of immune responses such that response to allergen exposure later in life is also more intense and leads to bronchial hyperreactivity. ALLERGEN AVOIDANCE & PREVENTION OF ATOPY – Food allergens avoidance Maternal dietary allergen avoidance during pregnancy does not prevent atopic disease in children and may be harmful to the fetus. Recent WHO report states that exclusive breast feeding and avoidance of solid food for 4 mo. seems to be effective for allergy prevention. Differential effect of breast feeding on the development of atopy, such that, children with atopic heredity, breast feeding reduced the risk of atopy while it increased the risk in those without atopic heredity. Cow’s milk protein is an important food allergen in early life. The incidence of allergic manifestations, such as AD, food allergy or allergic urticaria, was significantly reduced by using an extensively hydrolyzed casein formula compared with a cow’s milk formula. Use of partially hydrolyzed whey formula reduced the incidence of AD. ALLERGEN AVOIDANCE & PREVENTION OF ATOPY – Avoidance of aeroallergens To prevent the development of atopy (primary prevention), allergen avoidance has to be instituted before sensitization occurs. Avoidance measures would have to be applied from birth (or even during pregnancy). – Combined approach The Isle of Wight allergy prevention study was the first to show that a combination of strict avoidance of food and reduction in house dust mite allergens during infancy could have a profound effect on the development of atopy in genetically at risk children. There was a reduction in the incidence of asthma, atopic dermatitis and food allergy in early childhood. ALLERGEN AVOIDANCE & PREVENTION OF ATOPY Secondary prevention – Environmental allergen control is recommended as an essential part of most asthma management guidelines. Patients with asthma and aeroallergen sensitivities are appropriate advice on allergen avoidance and such measures can indeed reduce asthma symptoms, the need for medication, and airway hyperresponsiveness. Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations RESULTS: Of the 132 studies selected, 56 were regarded as conclusive. Several factors contributed to the exclusions. The studies considered conclusive by the review group were categorized according to population and study design. CONCLUSIONS: The review group concluded that breastfeeding seems to protect from the development of atopic disease. The effect appears even stronger in children with atopic heredity. If breast milk is unavailable or insufficient, extensively hydrolysed formulas are preferable to unhydrolysed or partially hydrolysed formulas in terms of the risk of some atopic manifestations. van Odijk et al., Allergy 2003;58:8332003;58:833-43. Recommendations for Atopy Prevention in high risk children: DIET – MATERNAL ROTARY DIET (4 DAYS CYCLE) INCREASE THE INTAKE OF n-3 FATTY ACIDS (FISH OILS) PROBIOTICS SUPPLEMENTATION AVOID OR MINIMIZE THE USE OF ORAL ANTIBIOTICS – INFANT EXCLUSIVE BREAST FEEDING FOR 4-6 MO AVOID INTRODUCTION OF SOLID FOODS AVOID INTRODUCTION OF ALLERGENIC FOODS FOR THE FIRST YEAR i.e. cow’s milk, egg, peanut. ALLERGEN AVOIDANCE – IMPLEMENT STRICT PERENNIAL AEROALLERGENS REDUCTION MEASURES DURING PREGNANCY (i.e. HDM, Molds, Insects (Cockroaches) and Pets) WITH HEPA AIR PURIFIERS, ACAROCIDES,FUNGIZIDES, TANNIC ACID AND HUMIDITY CONTROL. – IMPLEMENT STRICT PERENNIAL AEROALLERGENS BARRIER METHODS WITH MITE PROOF COVERS Recommendations for Atopy Prevention in high risk children: IMMUNOTHERAPY – START C.I.T. IN HIGH RISK MOTHER PRIOR TO PREGNANCY. – USE N.I.T. OR TEMP. DM C.I.T. – USE S.L.I.T. IN HIGH RISK INFANTS INFANTS FROM ATOPIC MOTHERS. INFANTS WITH SYMPTOMATIC SENSITIVITY. INFANTS WITH INCREASED IgE, IgG1 or TH2